Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoprotein

Current Topics in Membranes

Volumn 68, Issue , 2011, Pages 81-106

  Melikyan, Gregory B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endocytosis; Envelope glycoprotein; Fusion pore; Hemifusion; Trimeric hairpin; Virus fusion

Indexed keywords

VIRUS ENVELOPE PROTEIN;

BIOLOGICAL MODEL; CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE FUSION; METABOLISM; PHYSIOLOGY; POROSITY; REVIEW; VIRUS ASSEMBLY;

ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV; HUMANS; MEMBRANE FUSION; MODELS, BIOLOGICAL; POROSITY; VIRUS ASSEMBLY;

EID: 79960435702     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385891-7.00004-0     Document Type: Book

References (145)

1. Abrahamyan L.G., Markosyan R.M., Moore J.P., Cohen F.S., Melikyan G.B. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. Journa ofl Virology 2003, 77(10):5829-5836.
2. Agosto L.M., Yu J.J., Liszewski M.K., Baytop C., Korokhov N., Humeau L.M., et al. The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope. Journal of Virology 2009, 83(16):8153-8162. doi: JVI. 00220-09.
3. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. Journal of Virology 1997, 71(8):5871-5877.
4. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. Journal of Virology 1995, 69(8):5048-5056.
5. Aloia R.C., Tian H., Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(11):5181-5185.
6. Ashorn P.A., Berger E.A., Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. Journal of Virology 1990, 64(5):2149-2156.
7. Backovic M., Jardetzky T.S. Class III viral membrane fusion proteins. Current Opinion in Structural Biology 2009, 19(2):189-196.
8. Bedinger P., Moriarty A., von Borstel R.C., Donovan N.J., Steimer K.S., Littman D.R. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature 1988, 334(6178):162-165. 10.1038/334162a0.
9. Bellamy-McIntyre A.K., Lay C.S., Baar S., Maerz A.L., Talbo G.H., Drummer H.E., et al. Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion. Journal of Biological Chemistry 2007, 282(32):23104-23116.
10. Benaroch P., Billard E., Gaudin R., Schindler M., Jouve M. HIV-1 assembly in macrophages. Retrovirology 2010, 7:29. 1742-4690-7-29.
11. Benjamin J., Ganser-Pornillos B.K., Tivol W.F., Sundquist W.I., Jensen G.J. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. Journal of Molecular Biology 2005, 346(2):577-588.
12. Bennett A., Liu J., Van Ryk D., Bliss D., Arthos J., Henderson R.M., et al. Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120. Journal of Biological Chemistry 2007, 282(38):27754-27759.
13. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annual Review of Immunology 1999, 17:657-700.
14. Bewley C.A., Louis J.M., Ghirlando R., Clore G.M. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. Journal of Biological Chemistry 2002, 277(16):14238-14245.
15. Bieniasz P.D. The cell biology of HIV-1 virion genesis. Cell Host Microbe 2009, 5(6):550-558. doi: S1931-3128(09)00182-6.
16. Binley J.M., Cayanan C.S., Wiley C., Schulke N., Olson W.C., Burton D.R. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. Journal of Virology 2003, 77(10):5678-5684.
17. Binley J.M., Sanders R.W., Clas B., Schuelke N., Master A., Guo Y., et al. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. Journal of Virology 2000, 74(2):627-643.
18. Blanco J., Bosch B., Fernandez-Figueras M.T., Barretina J., Clotet B., Este J.A. High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells. Journal of Biological Chemistry 2004, 279(49):51305-51314. 10.1074/jbc.M408547200.
19. Borrego-Diaz E., Peeples M.E., Markosyan R.M., Melikyan G.B., Cohen F.S. Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology 2003, 316(2):234-244.
20. Briggs J.A., Wilk T., Welker R., Krausslich H.G., Fuller S.D. Structural organization of authentic, mature HIV-1 virions and cores. EMBO Journal 2003, 22(7):1707-1715.
21. Buzon V., Natrajan G., Schibli D., Campelo F., Kozlov M.M., Weissenhorn W. Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathogens 2010, 6(5):e1000880.
22. Caffrey M., Cai M., Kaufman J., Stahl S.J., Wingfield P.T., Covell D.G., et al. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO Journal 1998, 17(16):4572-4584.
23. Campbell E.M., Nunez R., Hope T.J. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. Journal of Virology 2004, 78(11):5745-5755. 10.1128/JVI.78.11.5745-5755.2004.
24. Chan D.C., Kim P.S. HIV entry and its inhibition. Cell 1998, 93(5):681-684.
25. Chan R., Uchil P.D., Jin J., Shui G., Ott D.E., Mothes W., et al. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. Journal of Virology 2008, 82(22):11228-11238. doi: JVI. 00981-08.
26. Chen A., Leikina E., Melikov K., Podbilewicz B., Kozlov M.M., Chernomordik L.V. Fusion-pore expansion during syncytium formation is restricted by an actin network. J Cell Sci 2008, 121(Pt 21):3619-3628. 121/21/3619.
27. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., Harrison S.C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433(7028):834-841.
28. Chernomordik L.V., Chanturiya A.N., Suss-Toby E., Nora E., Zimmerberg J. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. Journal of Virology 1994, 68(11):7115-7123.
29. Chernomordik L.V., Frolov V.A., Leikina E., Bronk P., Zimmerberg J. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation. Journal of Cell Biology 1998, 140(6):1369-1382.
30. Chien M.P, Jiang S., Chang D.K. The function of coreceptor as a basis for the kinetic dissection of HIV type 1 envelope protein-mediated cell fusion. Faseb Journal 2008, 22(4):1179-1192.
31. Chu H., Wang J.J., Spearman P. Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. Current Topics in Microbiology and Immunology 2009, 339:67-84. 10.1007/978-3-642-02175-6_4.
32. Clotet-Codina I., Bosch B., Senserrich J., Fernandez-Figueras M.T., Pena R., Ballana E., et al. HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection. Antiviral Research 2009, 83(1):94-98. doi: S0166-3542(09)00291-5.
33. Costin J.M. Cytopathic mechanisms of HIV-1. Virology Journal 2007, 4:100. doi: 1743-422X-4-100.
34. Daecke J., Fackler O.T., Dittmar M.T., Krausslich H.G. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. Journal of Virology 2005, 79(3):1581-1594.
35. Decker J.M., Bibollet-Ruche F., Wei X., Wang S., Levy D.N., Wang W., et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. Journal of Experimental Medicine 2005, 201(9):1407-1419.
36. Dimitrov A.S., Jacobs A., Finnegan C.M., Stiegler G., Katinger H., Blumenthal R. Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry 2007, 46(5):1398-1401.
37. Dimitrov A.S., Louis J.M., Bewley C.A., Clore G.M., Blumenthal R. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry 2005, 44(37):12471-12479.
38. Doranz B.J., Baik S.S., Doms R.W. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events. Journal of Virology 1999, 73(12):10346-10358.
39. Eckert D.M., Kim P.S. Mechanisms of Viral Membrane Fusion and Its Inhibition. Annual Review of Biochemistry 2001, 70:777-810.
40. Edwards T.G., Hoffman T.L., Baribaud F., Wyss S., LaBranche C.C., Romano J., et al. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. Journal of Virology 2001, 75(11):5230-5239.
41. Fackler O.T, Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., et al. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. European Journal of Biochemistry 1997, 247(3):843-851.
42. Fackler O.T., Luo W., Geyer M., Alberts A.S., Peterlin B.M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Molecular Cell 1999, 3(6):729-739. doi: S1097-2765(01)80005-8.
43. Felts R.L., Narayan K., Estes J.D., Shi D., Trubey C.M., Fu J., et al. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(30):13336-13341. doi: 1003040107.
44. Finnegan C.M., Berg W., Lewis G.K., DeVico A.L. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion. Journal of Virology 2002, 76(23):12123-12134.
45. Fischer P.B., Karlsson G.B., Dwek R.A., Platt F.M. N-Butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure. Journal of Virology 1996, 70(10):7153-7160.
46. Fredericksen B.L., Wei B.L., Yao J., Luo T., Garcia J.V. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. Journal of Virology 2002, 76(22):11440-11446.
47. Freed E.O., Martin M.A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. Journal of Biological Chemistry 1995, 270(41):23883-23886.
48. Freed E.O., Mouland A.J. The cell biology of HIV-1 and other retroviruses. Retrovirology 2006, 3:77.
49. Fu Y.K., Hart T.K., Jonak Z.L., Bugelski P.J. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. Journal of Virology 1993, 67(7):3818-3825.
50. Furuta R.A., Wild C.T., Weng Y., Weiss C.D. Capture of an early fusion-active conformation of HIV-1 gp41. Nature Structural & Molecular Biology 1998, 5(4):276-279.
51. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A., Rawat S.S., et al. The HIV Env-mediated fusion reaction. Biochimica et Biophysica Acta 2003, 1614(1):36-50.
52. Gallo S.A., Puri A., Blumenthal R. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry 2001, 40(41):12231-12236.
53. Golding H., Zaitseva M., de Rosny E., King L.R., Manischewitz J., Sidorov I., et al. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. Journal of Virology 2002, 76(13):6780-6790.
54. Gustchina E., Bewley C.A., Clore G.M. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41. Journal of Virology 2008, 82(20):10032-10041.
55. Haim H, Si Z., Madani N., Wang L., Courter J.R., Princiotto A., et al. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathogens 2009, 5(4):e1000360.
56. Harmon B., Campbell N., Ratner L. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathogens 2010, 6(6):e1000956. 10.1371/journal.ppat.1000956.
57. Harmon B., Ratner L. Induction of the Galpha(q) signaling cascade by the human immunodeficiency virus envelope is required for virus entry. Journal of Virology 2008, 82(18):9191-9205. doi: JVI. 00424-08.
58. Harrison S.C. Viral membrane fusion. Nature Structural & Molecular Biology 2008, 15(7):690-698.
59. Henderson H.I., Hope T.J. The temperature arrested intermediate of virus-cell fusion is a functional step in HIV infection. Virology Journal 2006, 3:36.
60. Hildinger M., Dittmar M.T., Schult-Dietrich P., Fehse B., Schnierle B.S., Thaler S., et al. Membrane-anchored peptide inhibits human immunodeficiency virus entry. Journal of Virology 2001, 75(6):3038-3042.
61. Hubner W., McNerney G.P., Chen P., Dale B.M., Gordon R.E., Chuang F.Y., et al. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 2009, 323(5922):1743-1747.
62. Jiang J., Aiken C. Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 2006, 346(2):460-468.
63. Jiang J., Aiken C. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. Journal of Virology 2007, 81(18):9999-10008.
64. Jolly C., Kashefi K., Hollinshead M., Sattentau Q.J. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. Journal of Experimental Medicine 2004, 199(2):283-293.
65. Kahle K.M, Steger H.K., Root M.J. Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding. PLoS Pathogens 2009, 5(11):e1000674. 10.1371/journal.ppat.1000674.
66. Kassa A., Finzi A., Pancera M., Courter J.R., Smith A.B., Sodroski J. Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation. Journal of Virology 2009, 83(9):4476-4488. doi: JVI. 02110-08.
67. Kielian M., Rey F.A. Virus membrane-fusion proteins: More than one way to make a hairpin. Nature Reviews Microbiology 2006, 4(1):67-76.
68. Kilgore N.R., Salzwedel K., Reddick M., Allaway G.P., Wild C.T. Direct evidence that C-peptide inhibitors of human immunodeficiency virus type 1 entry bind to the gp41 N-helical domain in receptor-activated viral envelope. Journal of Virology 2003, 77(13):7669-7672.
69. Klasse P.J. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology 2007, 369(2):245-262.
70. Kliger Y., Shai Y. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. Journal of Molecular Biology 2000, 295(2):163-168.
71. Kozak S.L., Platt E.J., Madani N., Ferro F.E., Peden K., Kabat D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. Journal of Virology 1997, 71(2):873-882.
72. Kwong P.D, Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [see comments]. Nature 1998, 393(6686):648-659.
73. Labrijn A.F., Poignard P., Raja A., Zwick M.B., Delgado K., Franti M., et al. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. Journal of Virology 2003, 77(19):10557-10565.
74. Lamb R.A., Jardetzky T.S. Structural basis of viral invasion: Lessons from paramyxovirus F. Current Opinion in Structural Biology 2007, 17(4):427-436.
75. Lay C.S., Wilson K.A., Kobe B., Kemp B.E., Drummer H.E., Poumbourios P. Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: Determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core. FEBS Letter 2004, 567(2-3):183-188. 10.1016/j.febslet.2004.04.054.
76. Le Blanc I., Luyet P.P., Pons V., Ferguson C., Emans N., Petiot A., et al. Endosome-to-cytosol transport of viral nucleocapsids. Nature Cell Biology 2005, 7(7):653-664.
77. Lee S.F., Ko C.Y., Wang C.T., Chen S.S. Effect of point mutations in the N terminus of the lentivirus lytic peptide-1 sequence of human immunodeficiency virus type 1 transmembrane protein gp41 on Env stability. Journal of Biological Chemistry 2002, 277(18):15363-15375. 10.1074/jbc.M201479200.
78. Liu J., Bartesaghi A., Borgnia M.J., Sapiro G., Subramaniam S. Molecular architecture of native HIV-1 gp120 trimers. Nature 2008, 455(7209):109-113. doi: nature07159.
79. Maddon P.J., McDougal J.S., Clapham P.R., Dalgleish A.G., Jamal S., Weiss R.A., et al. HIV infection does not require endocytosis of its receptor. CD4. Cell 1988, 54(6):865-874.
80. Magnus C., Rusert P., Bonhoeffer S., Trkola A., Regoes R.R. Estimating the stoichiometry of HIV entry. Journal of Virology 2008, 83(3):1523-1531.
81. Marechal V., Prevost M.C., Petit C., Perret E., Heard J.M., Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. Journal of Virology 2001, 75(22):11166-11177.
82. Markosyan R.M., Cohen F.S., Melikyan G.B. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Molecular Biology of the Cell 2000, 11(4):1143-1152.
83. Markosyan R.M., Cohen F.S., Melikyan G.B. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Molecular Biology of the Cell 2003, 14(3):926-938.
84. Martin N., Welsch S., Jolly C., Briggs J.A., Vaux D., Sattentau Q.J. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. Journal of Virology 2010, 84(7):3516-3527. doi: JVI. 02651-09.
85. McClure M.O., Marsh M., Weiss R.A. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO Journal 1988, 7(2):513-518.
86. Melikyan G.B. Common principles and intermediates of viral protein-mediated fusion: The HIV-1 paradigm. Retrovirology 2008, 5(1):111.
87. Melikyan G.B., Brener S.A., Ok D.C., Cohen F.S. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. Journal of Cell Biology 1997, 136:995-1005.
88. Melikyan G.B., Egelhofer M., von Laer D. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. Journal of Virology 2006, 80(7):3249-3258.
89. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., Cohen F.S. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. Journal of Cell Biology 2000, 151(2):413-424.
90. Miller M.D., Warmerdam M.T., Gaston I., Greene W.C., Feinberg M.B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. Journal of Experimental Medicine 1994, 179(1):101-113.
91. Mische C.C., Yuan W., Strack B., Craig S., Farzan M., Sodroski J. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor. Virology 2005, 338(1):133-143.
92. Miyauchi K., Kim Y., Latinovic O., Morozov V., Melikyan G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137(3):433-444.
93. Miyauchi K., Kozlov M.M., Melikyan G.B. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation. PLoS Pathogens 2009, 5(9):e1000585. 10.1371/journal.ppat.1000585.
94. Mkrtchyan S.R., Markosyan R.M., Eadon M.T., Moore J.P., Melikyan G.B., Cohen F.S. Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion. Journal of Virology 2005, 79(17):11161-11169.
95. Montero M, van Houten N.E., Wang X., Scott J.K. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design. Microbiology and Molecular Biology Reviews 2008, 72(1):54-84. table of contents.
96. Morita E., Sundquist W.I. Retrovirus budding. Annual Review of Cell and Developmental Biology 2004, 20:395-425.
97. Munoz-Barroso I., Durell S., Sakaguchi K., Appella E., Blumenthal R. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. Journal of Cell Biology 1998, 140(2):315-323.
98. Munoz-Barroso I., Salzwedel K., Hunter E., Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. Journal of Virology 1999, 73(7):6089-6092.
99. Murakami T., Ablan S., Freed E.O., Tanaka Y. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. Journal of Virology 2004, 78(2):1026-1031.
100. Murakami T., Freed E.O. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions [In Process Citation]. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(1):343-348.
101. Ohno H., Aguilar R.C., Fournier M.C., Hennecke S., Cosson P., Bonifacino J.S. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 1997, 238(2):305-315. doi: S0042-6822(97)98839-5.
102. Orloff S.L., Kennedy M.S., Belperron A.A., Maddon P.J., McDougal J.S. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4. Journal of Virology 1993, 67(3):1461-1471.
103. Pace, M.J., Agosto, L., & O'Doherty, U. (2010). R5 HIV Env and VSV-G Cooperate to Mediate Fusion to Naive CD4+T Cells. Journal of Virology. doi: JVI. 01851-10.
104. Pauza C.D., Price T.M. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. Journal of Cell Biology 1988, 107(3):959-968.
105. Pelchen-Matthews A., Clapham P., Marsh M. Role of CD4 endocytosis in human immunodeficiency virus infection. Journal of Virology 1995, 69(12):8164-8168.
106. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003, 162(3):443-455.
107. Permanyer M., Ballana E., Este J.A. Endocytosis of HIV: Anything goes. Trends Microbiol 2010, 18(12):543-551. doi: S0966-842X(10)00171-X.
108. Pontow S.E., Heyden N.V., Wei S., Ratner L. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion. Journal of Virology 2004, 78(13):7138-7147.
109. Richard J.P., Leikina E., Chernomordik L.V. Cytoskeleton reorganization in influenza hemagglutinin-initiated syncytium formation. Biochim Biophys Acta 2009, 1788(2):450-457. doi: S0005-2736(08)00308-8.
110. Salzwedel K., Berger E.A. Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: A general property of the functional trimer. Retrovirology 2009, 6:75. doi: 1742-4690-6-75.
111. Salzwedel K., Smith E.D., Dey B., Berger E.A. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: Soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. Journal of Virology 2000, 74(1):326-333.
112. Sattentau Q.J., Moore J.P. The role of CD4 in HIV binding and entry. Philosophical Transactions of the Royal Society B: Biological Sciences 1993, 342(1299):59-66.
113. Sattentau Q.J., Moore J.P., Vignaux F., Traincard F., Poignard P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. Journal of Virology 1993, 67(12):7383-7393.
114. Schaeffer E., Soros V.B., Greene W.C. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. Journal of Virology 2004, 78(3):1375-1383.
115. Skehel J.J., Wiley D.C. Coiled coils in both intracellular vesicle and viral membrane fusion. Cell 1998, 95(7):871-874.
116. Stantchev T.S., Markovic I., Telford W.G., Clouse K.A., Broder C.C. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Research 2007, 123(2):178-189.
117. Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987, 49(5):659-668.
118. Sullivan N., Sun Y., Sattentau Q., Thali M., Wu D., Denisova G., et al. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization. Journal of Virology 1998, 72(6):4694-4703.
119. Thali M., Furman C., Helseth E., Repke H., Sodroski J. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. Journal of Virology 1992, 66(9):5516-5524.
120. Thali M., Moore J.P., Furman C., Charles M., Ho D.D., Robinson J., et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. Journal of Virology 1993, 67(7):3978-3988.
121. Tobiume M., Lineberger J.E., Lundquist C.A., Miller M.D., Aiken C. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. Journal of Virology 2003, 77(19):10645-10650.
122. Vishwanathan S.A., Hunter E. Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion. Journal of Virology 2008, 82(11):5118-5126.
123. Waheed A.A., Freed E.O. The Role of Lipids in Retrovirus Replication. Viruses 2010, 2(5):1146-1180. doi: 10.3390/v2051146.
124. Wei B.L., Denton P.W., O'Neill E., Luo T., Foster J.L., Garcia J.V. Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. Journal of Virology 2005, 79(9):5705-5712.
125. Wexler-Cohen Y., Shai Y. Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action. PLoS Pathogens 2009, 5(7):e1000509. 10.1371/journal.ppat.1000509.
126. White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Critical Reviews in Biochemistry and Molecular Biology 2008, 43(3):189-219.
127. Willey R.L., Bonifacino J.S., Potts B.J., Martin M.A., Klausner R.D. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proceedings of the National Academy of Sciences of the United States of America 1988, 85(24):9580-9584.
128. Willey R.L., Martin M.A., Peden K.W. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. Journal of Virology 1994, 68(2):1029-1039.
129. Wu L., Zhou T., Yang Z.Y., Svehla K., O'Dell S., Louder M.K., et al. Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain. Journal of Virology 2009, 83(10):5077-5086. doi: JVI. 02600-08.
130. Wu S.R., Loving R., Lindqvist B., Hebert H., Koeck P.J., Sjoberg M., et al. Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(44):18844-18849. doi: 1007227107.
131. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998, 393(6686):705-711.
132. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 1998, 280(5371):1884-1888.
133. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., et al. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: A novel role of the gp41 cytoplasmic tail. Journal of Virology 2004, 78(7):3429-3435.
134. Wyma D.J., Kotov A., Aiken C. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. Journal of Virology 2000, 74(20):9381-9387.
135. Wyss S., Dimitrov A.S., Baribaud F., Edwards T.G., Blumenthal R., Hoxie J.A. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. Journal of Virology 2005, 79(19):12231-12241. doi: 79/19/12231.
136. Yang P., Ai L.S., Huang S.C., Li H.F., Chan W.E., Chang C.W., et al. The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants. Journal of Virology 2010, 84(1):59-75. doi: JVI. 00899-09.
137. Yang X., Kurteva S., Ren X., Lee S., Sodroski J. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. Journal of Virology 2005, 79(19):12132-12147.
138. Yoder A., Yu D., Dong L., Iyer S.R., Xu X., Kelly J., et al. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134(5):782-792.
139. Yu D., Wang W., Yoder A., Spear M., Wu Y. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathogens 2009, 5(10):e1000633. 10.1371/journal.ppat.1000633.
140. Yuan W., Bazick J., Sodroski J. Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker. Journal of Virology 2006, 80(14):6725-6737.
141. Zaitseva E., Mittal A., Griffin D.E., Chernomordik L.V. Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J Cell Biol 2005, 169(1):167-177.
142. Zaitseva E., Yang S.-T., Melikov K., Pourmal S., Chernomordik L.V. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathogens 2010, 6(10):e1001131. 10.1371/journal.ppat.1001131.
143. Zanetti G., Briggs J.A., Grunewald K., Sattentau Q.J., Fuller S.D. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathogens 2006, 2(8):e83.
144. Zhu P., Liu J., Bess J., Chertova E., Lifson J.D., Grise H., et al. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 2006, 441(7095):847-852.
145. Zhu P., Winkler H., Chertova E., Taylor K.A., Roux K.H. Cryoelectron tomography of HIV-1 envelope spikes: Further evidence for tripod-like legs. PLoS Pathogens 2008, 4(11):e1000203. 10.1371/journal.ppat.1000203.